Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Epsilon Molecular Engineering Inc. logo — Epsilon Molecular Engineering (EME) Inc. is the cDNA display...

Epsilon Molecular Engineering Inc.

Epsilon Molecular Engineering (EME) Inc. is the cDNA display technology-based bio-pharmaceutical drug discovery company.

Founded 2016 Japan Japan 5 employees Series A Total: $510.00M Biotechnology, Care Economy +1

General Information

Company Name Epsilon Molecular Engineering Inc.
Founded Year 2016
Location Japan Japan +1
Employees 5
Industries Biotechnology, Care Economy, Internet
Funding Stage Series A
Social

Get notified when Epsilon Molecular Engineering Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Epsilon Molecular Engineering Inc.

Epsilon Molecular Engineering (EME) Inc. is a biotechnology startup that specializes in bio-pharmaceutical drug discovery using evolutionary molecular engineering. Established in 2016 as a venture company from Saitama University in Japan, EME boasts proprietary technologies and unique cDNA display libraries of heavy chain single domain antibodies (VHH) and cyclic peptides with a large diversity of 10^13-14 . They utilize high-throughput screening methods employing next-generation sequencing, FACS, and machine learning (bioinformatics). The company is currently involved in several joint research projects, including COVID-19, and 17 ongoing in-house projects encompassing areas such as cancer, inflammation, and Alzheimer’s disease. In December 2020, EME secured a notable ¥280.00M Series A investment from a consortium of investors including Mitsubishi UFJ Capital, Shoko Chukin Bank, Resona Bank, REVIC, Gungin Consulting, and Kao Corporation for further advancement in their research and development endeavors. EME's innovative approach to drug discovery and strong collaboration with reputable institutions positions them as a promising player in the biopharmaceutical industry. With a solid foundation and a robust network of investors, EME is well-positioned to make significant strides in the biotechnology landscape.

Taxonomy: Biopharmaceutical, Drug discovery, cDNA display technology, Molecular engineering, Venture company, Proprietary technologies, Antibody libraries, High-throughput screening, Next-generation sequencing, FACS, Machine learning, Bioinformatics, COVID-19 research, Cancer research, Inflammation research

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 6
Investor Investor Investor Investor
•••• •••• 		23 Dec 2020
Series A •••••• 2
Investor Investor
23 Oct 2019
Seed Round •••••• 1
Investor
13 Nov 2017

Epsilon Molecular Engineering Inc. Alternatives & Competitors

Epsilon Molecular Engineering Inc. vs
EME Engineering Inc.
EME Engineering Inc. Canada

RELIABLE, QUALITY ENGINEERING FROM EXPERIENCED PROBLEM SOLVERS

10 employees
Renewable Energy
Compare Epsilon Molecular Engineering Inc. vs EME Engineering Inc.
Epsilon Molecular Engineering Inc. vs
EME Consulting Engineering and Architecture Group, LLC
EME Consulting Engineering and Architecture Group, LLC United States

Engineered Solutions

81 employees
Epsilon Molecular Engineering Inc. vs
Isohelix
Isohelix United Kingdom

Manufacturer of high performance Buccal, Saliva and Microbiome DNA & RNA collection, Stabilization a...

5 employees
Biotechnology, Manufacturing

FAQ About Epsilon Molecular Engineering Inc.

Epsilon Molecular Engineering (EME) Inc. is the cDNA display technology-based bio-pharmaceutical drug discovery company.
Epsilon Molecular Engineering Inc. was founded in 2016.
Epsilon Molecular Engineering Inc. is headquartered in Japan.
Epsilon Molecular Engineering Inc. operates in the following industries: Biotechnology, Care Economy, Internet.
Epsilon Molecular Engineering Inc. has approximately 5 employees.
Epsilon Molecular Engineering Inc. has completed 3 funding rounds, raising a total of $510.00M. The latest funding stage is Series A.
Top alternatives and competitors to Epsilon Molecular Engineering Inc. include EME Engineering Inc., EME Consulting Engineering and Architecture Group, LLC, Isohelix, Calder Biosciences Inc., Molecular Designs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Epsilon Molecular Engineering Inc. and EME Engineering Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Epsilon Molecular Engineering Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes